AquaBounty Abandons Approved Reverse Stock Split Plan
AQB sits 51% above its 52-week low of $0.7.
Summary
AquaBounty's board has decided not to implement the previously approved 1-for-5 to 1-for-20 reverse stock split, letting the authority expire on July 31, 2026. This decision comes after shareholders approved the split on June 25, which was intended to boost the company's share price. The company had previously issued a 'going concern' warning in its Q1 10-Q filing due to low cash balances and a net loss. Declining to proceed with the split removes a key mechanism for maintaining NASDAQ listing compliance and could signal a lack of a clear strategy to address its low share price and financial challenges.
At the time of this announcement, AQB was trading at $1.06 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5M. The 52-week trading range was $0.70 to $2.95. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.